CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM NEW
Total 13F shares
2,886,437
Share change
-293,591
Total reported value
$634,289
Put/Call ratio
4%
Price per share
$0.22
Number of holders
31
Value change
-$122,289
Number of buys
13
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q4 2022

As of 31 Dec 2022, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,886,437 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Bank of New York Mellon Corp, NORTHERN TRUST CORP, Virtu Financial LLC, SIGNATUREFD, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and STATE STREET CORP. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.